• About Us
    • Contact Us
    • Login
    • ObGFirst
  • COVID-19
  • Alerts
  • OB
  • 2T US Atlas
  • The Genome
  • GYN
    • GYN
    • Sexual Health
  • Primary Care
  • Your Practice
  • #GrandRounds
  • My Bookshelf
  • Now@ObG
  • Media
About Us Contact Us Login ObGFirst
  • COVID-19
  • Alerts
  • OB
  • 2T US Atlas
  • The Genome
  • GYN
    • 0 CME Hours
    • GYN
    • Sexual Health
  • Primary Care
  • Your Practice
  • #GrandRounds
  • My Bookshelf
  • Now@ObG
  • Media
#Grand Rounds

How do Walnuts Improve Appetite and Glycemic Control?

image_pdfFavoriteLoadingFavorite

BACKGROUND AND PURPOSE: 

  • Nuts appear to reduce risk of cardiovascular disease (CVD)  
  • Walnuts in particular are recommended for obesity and type 2 diabetes 
    • Mechanism through which walnuts impact appetite and glycemic control is unknown 
  • Farr et al. (Diabetes, Obesity and Metabolism. 2018) sought to determine whether walnut consumption impacts the neural control of appetite  

METHODS: 

  • Randomized, placebo-controlled, double-blind, cross-over trial  
  • 10 adult individuals with obesity (BMI ≥30 kg/m2) were included  
  • Participants were randomized to 48 g of walnuts per day or an isocaloric diet without walnuts 
  • Patients lived for 5 days in a controlled environment of a clinical research center, during which they were fed either walnuts or placebo using a smoothie delivery system 
  • Functional Magnetic Resonance Imaging (fMRI) was used to detect parts of the brain involved 
  • Visual analog scales (VAS) were used to measure subjective feelings of hunger, appetite, and fullness 
  • After 5 days, participants were discharged home and placed back on a normal diet for a period of 5 weeks and then returned for a further 5 days 
  • Control and exposure groups crossed over for a second series of 5 days   
  • Small number of participants, but authors did power the study to answer the question  
  • Primary outcome 
    • To determine how walnuts impact eating behaviors by altering neural responses to visual cues 

RESULTS: 

  • 9 participants completed both 5 day series, including fMRI  
  • Walnut consumption decreased feelings of hunger and appetite 
  • Patients that ate walnuts had an increased activation of the right insula in response to highly desirable food cues 
  • When participants received walnuts, they reported that  
    • They were less hungry compared to when they received placebo on VAS (placebo, 7.65 ± 0.99; walnut, 6.12 ± 1.16; P < .05)  
    • They could eat a smaller quantity of food while consuming walnuts (placebo, 7.55 ± 0.99; walnuts, 6.44 ± 1.01; P < .04) 

CONCLUSION: 

  • Eating walnuts may increase satiety and cognitive control when faced with highly desirable foods 
  • Walnuts may work by activating the right insula in the brain 
  • The authors suggest that increased activation of the insula may indicate increased inhibitory control in the face of highly desirable (high-fat) food cues  
  • Further studies required to determine if this response was specific to walnuts or may be generalizable to other nuts 

Learn More – Primary Sources: 

Walnut consumption increases activation of the insula to highly desirable food cues: A randomized, double-blind, placebo-controlled, cross-over fMRI study 

image_pdfFavoriteLoadingFavorite

< Previous
All #Grand Rounds Posts
Next >

Related ObG Topics:

Does Bariatric Surgery Decrease Cancer Risk?
PURE Study Results – Carbs vs Fat Intake to Reduce Cardiovascular Morbidity and Mortality?

Sections

  • COVID-19
  • Alerts
  • OB
  • GYN
    • GYN
    • Sexual Health
  • 2T US Atlas
  • The Genome
  • Primary Care
  • Your Practice
  • #Grand Rounds
  • My Bookshelf
  • Now@ObG
  • Media

ObG Library

  • Hysteroscopy
  • Fertility
  • Site Map/
  • © ObG Project/
  • Terms and Conditions/
  • Privacy/
  • Contact Us/
© ObG Project
SSL Certificate


  • Already an ObGFirst Member?
    Welcome back

    Log In

    Want to sign up?
    Get guideline notifications
    CME Included

    Sign Up

Get Guideline Alerts Direct to Your Phone
Try ObGFirst Free!

Sign In

Lost your password?

Sign Up for ObGFirst and Stay Ahead

  • - Professional guideline notifications
  • - Daily summary of a clinically relevant
    research paper
  • - Includes 1 hour of CME every month

ObGFirst Free Trial

Log In to ObG First

Please log in to access OBGFirst and the 2T Ultrasound Atlas

Password Trouble?

Sign Up for ObGFirst

  • - Access 2T US Atlas
  • - Guideline notifications
  • - Daily research paper summaries
  • - And lots more!

ObG First Free Trial

Media - Internet

Computer System Requirements

OBG Project CME requires a modern web browser (Internet Explorer 10+, Mozilla Firefox, Apple Safari, Google Chrome, Microsoft Edge). Certain educational activities may require additional software to view multimedia, presentation, or printable versions of their content. These activities will be marked as such and will provide links to the required software. That software may be: Adobe Flash, Apple QuickTime, Adobe Acrobat, Microsoft PowerPoint, Windows Media Player, or Real Networks Real One Player.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information
presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Jointly provided by

NOT ENOUGH CME HOURS

It appears you don't have enough CME Hours to take this Post-Test. Feel free to buy additional CME hours or upgrade your current CME subscription plan

Subscribe

JOIN OBGFIRST AND GET CME/CE CREDITS

One of the benefits of an ObGFirst subscription is the ability to earn CME/CE credits from the ObG entries you read. Tap the button to learn more about ObGFirst

Learn More
Leaving ObG Website

You are now leaving the ObG website and on your way to PRIORITY at UCSF, an independent website. Therefore, we are not responsible for the content or availability of this site